Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVIENT CORPAVNT · Entity 4061 | SVP & Chief Technology Officer | February 22, 2024 | February 26, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVIENT CORP
Report date February 22, 2024 · Filed February 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $39.27 · Expires 2034-02-22 | Direct | 14,400 |
Reported balance
After 2024-02-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-22 · Grant · Acquired 14,400 · Balance 14,400 F1: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $39.27 per share and no more than one-third of the grant can vest per year during the first three years. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-02-22 | Direct | 4,450 |
Reported balance
After 2024-02-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-02-22 · Grant · Acquired 4,450 · Balance 4,450 F2: Each restricted stock unit represents a contingent right to receive one share of Avient common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $39.27 per share and no more than one-third of the grant can vest per year during the first three years.
F2: Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2024 Filed Feb 26, 2024 19:17 UTC | AVIENT CORP AVNT · Entity 4061 | GrantRestricted Stock Units · Derivative | 4,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006814 · form4.xml · derivative · entry 2 Purayath Vinod Robert · CIK 0001859440 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,450 Underlying: Common Stock · 4,450 shares Expires 2027-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Avient common stock. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 19:17 UTC | AVIENT CORP AVNT · Entity 4061 | GrantStock Appreciation Rights · Derivative | 14,400 | $0.00 Strike: $39.27 | $0.00 |
DisclosureSEC source: 0001127602-24-006814 · form4.xml · derivative · entry 1 Purayath Vinod Robert · CIK 0001859440 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,400 Underlying: Common Stock · 14,400 shares Expires 2034-02-22 F1 · derivative.exercise_date: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $39.27 per share and no more than one-third of the grant can vest per year during the first three years. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 16:53 UTC | AVIENT CORP AVNT · Entity 4061 | GrantStock Appreciation Rights · Derivative | 12,050 | $0.00 Strike: $42.93 | $0.00 |
DisclosureSEC source: 0001127602-23-006158 · form4.xml · derivative · entry 2 Purayath Vinod Robert · CIK 0001859440 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,050 Underlying: Common Stock · 12,050 shares Expires 2033-02-17 F2 · derivative.exercise_date: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 16:53 UTC | AVIENT CORP AVNT · Entity 4061 | GrantRestricted Stock Units · Derivative | 3,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006158 · form4.xml · derivative · entry 1 Purayath Vinod Robert · CIK 0001859440 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550 Underlying: Common Stock · 3,550 shares Expires 2026-02-17 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Avient common stock. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:49 UTC | AVIENT CORP AVNT · Entity 4061 | GrantStock Appreciation Rights · Derivative | 10,250 | $0.00 Strike: $52.64 | $0.00 |
DisclosureSEC source: 0001127602-22-005033 · form4.xml · derivative · entry 2 Purayath Robert Vinod · CIK 0001859440 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250 Underlying: Common Stock · 10,250 shares Expires 2032-02-14 F2 · derivative.exercise_date: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:49 UTC | AVIENT CORP AVNT · Entity 4061 | GrantRestricted Stock Units · Derivative | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-005033 · form4.xml · derivative · entry 1 Purayath Robert Vinod · CIK 0001859440 · SVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 Underlying: Common Stock · 2,900 shares Expires 2025-02-14 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Avient common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.